Fig. 4

Validation of the prognostic model. A According to the median score of the prognostic model, patients were divided into high score group and low score group (Cutoff = 0.0097). B The scatter plot showed that more patients survived in the low score group (red represents death, blue represents survival). C Among all AML patients with OS data, AML patients in the high group had worse prognostic survival than those in the low group (n = 1229, P < 0.001). D The 1-, 2-, 3-, and 5-year AUC of AML patients obtained by the prognostic model were 0.77, 0.79, 0.81, and 0.77, respectively. E In GSE37642, the prognostic survival of AML patients in the higher group was shorter (n = 553, P < 0.001). F In GSE10358, AML patients with high score had a worse prognosis than patients with low score (n = 91, P < 0.001). G In GSE12417, which was all CN-AML, patients in the high group had worse prognostic survival than those in the low group (n = 242, P < 0.001). OS, overall survival; CN-AML, cytogenetically normal AML; AUC, area under the curve